These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15172171)

  • 1. Liposomal gels for vaginal drug delivery.
    Pavelić Z; Skalko-Basnet N; Schubert R; Jalsenjak I
    Methods Enzymol; 2004; 387():287-99. PubMed ID: 15172171
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
    Ning M; Gu Z; Pan H; Yu H; Xiao K
    Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
    Karimunnisa S; Atmaram P
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gels as vaginal drug delivery systems.
    das Neves J; Bahia MF
    Int J Pharm; 2006 Aug; 318(1-2):1-14. PubMed ID: 16621366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vagina as a route for systemic drug delivery.
    Hussain A; Ahsan F
    J Control Release; 2005 Mar; 103(2):301-13. PubMed ID: 15763615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal gel with chloramphenicol: characterisation and in vitro release.
    Pavelić Z; Skalko-Basnet N; Jalsenjak I
    Acta Pharm; 2004 Dec; 54(4):319-30. PubMed ID: 15634615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal mucoadhesive drug delivery systems.
    de Araújo Pereira RR; Bruschi ML
    Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole.
    Ning M; Guo Y; Pan H; Chen X; Gu Z
    Drug Dev Ind Pharm; 2005 May; 31(4-5):375-83. PubMed ID: 16093203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design.
    Chopra S; Motwani SK; Iqbal Z; Talegaonkar S; Ahmad FJ; Khar RK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):120-31. PubMed ID: 17270408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin.
    Berginc K; Suljaković S; Škalko-Basnet N; Kristl A
    Eur J Pharm Biopharm; 2014 May; 87(1):40-6. PubMed ID: 24534774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy.
    Andersen T; Bleher S; Eide Flaten G; Tho I; Mattsson S; Škalko-Basnet N
    Mar Drugs; 2015 Jan; 13(1):222-36. PubMed ID: 25574737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery by the intravaginal route.
    Woolfson AD; Malcolm RK; Gallagher R
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):509-55. PubMed ID: 11108158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The materials engineering of temperature-sensitive liposomes.
    Mills JK; Needham D
    Methods Enzymol; 2004; 387():82-113. PubMed ID: 15172159
    [No Abstract]   [Full Text] [Related]  

  • 15. Liposomal gels for vaginal drug delivery.
    Pavelić Z; Skalko-Basnet N; Schubert R
    Int J Pharm; 2001 May; 219(1-2):139-49. PubMed ID: 11337174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
    Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel.
    Vanić Ž; Hurler J; Ferderber K; Golja Gašparović P; Škalko-Basnet N; Filipović-Grčić J
    J Liposome Res; 2014 Mar; 24(1):27-36. PubMed ID: 23931627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis.
    Pavelić Z; Skalko-Basnet N; Jalsenjak I
    Int J Pharm; 2005 Sep; 301(1-2):140-8. PubMed ID: 16024188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antibody delivery systems produce sustained levels in mucosal tissue and blood.
    Kuo PY; Sherwood JK; Saltzman WM
    Nat Biotechnol; 1998 Feb; 16(2):163-7. PubMed ID: 9487523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to prolong the intravaginal residence time of drug delivery systems.
    Baloglu E; Senyigit ZA; Karavana SY; Bernkop-Schnürch A
    J Pharm Pharm Sci; 2009; 12(3):312-36. PubMed ID: 20067707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.